MediChain

MediChain

Created using Figma
Created using Figma
MediChainはメディカルビッグデータプラットフォームです。患者は適切な地理的領域に自分のデータをオフチェーンで保管し、使用された支払人ネットワークやEMRに関係なく、医者や専門家にアクセスすることができます。
3月, 2018
4月, 2018
100% completed
Raised funds - no Data
硬質キャップ 40 000 000 USD
past
  • 1 MCU
    =
    1 USD
Token Details
Ticker
MCU
Accepted Currencies
ETH, BTC, USD, LTC, BCH, ZEC, DASH, NEO, FIAT, VARIOUS
Company Details
Registered Country
United Kingdom
Additional Details
Platform
Ethereum
KYC
Yes
Categories
プラットフォーム, 健康, スマート契約, ビッグデータ

約 MediChain

ブロックチェーンで人生を保存する

Medichainはメディカルビッグデータプラットフォームです。患者は適切な地理的領域にチェーンから自分のデータを保管し、使用された支払人ネットワークやEMRに関係なく、医者や専門家にアクセスすることができます。 MediChainは、患者のソリューションを提供するだけでなく、ビデオの上の最初のテキストでデータの価値を大きなデータとして活用するだけで、医療記録でもユニークです。 

特徴

MediChainは、患者の解決策を提供するだけでなく、データの価値を大きなデータとして活用するだけで、医療記録が不安定です。

MediChain Roadmap

  • Q1 2018

  • Public MVP
    System live and scaled on Rackspace servers
    Research
    Scientist program, 10+ rolling grants to get high quality data
    Pharma
    Outreach program to determine data needs
    Stakeholder
    Data stakeholder program starts to ensure buy-in
    HIPAA & FDA
    Compliance completed
    Research
    Outreach program 1-3 grants gets best data
    Team Growth
    Headhunting world class talent in line with needs
    Talent Search
    Attracting great talent. Includes hackathons
    Partner Creation
    Research and build high value data partners
    Pharma
    Partnerships developing 10-15 companies
  • Public MVP

  • MedRec system live and scaled on rackspace servers
  • Q2 2018

  • Research
    Scientist Program, 3-5 grants to get high value data
    EHR/EMR
    Integration between EMR and MediChain completed
    Analysis
    Ongoing operational needs analysis
  • 2018

  • Public MVP
    Research
    Pharma
    Stakeholder
    HIPAA & FDA
    Research
    Team Growth
    Talent Search
    Partner Creation
    Pharma
    Research
    EHR/EMR
    Analysis
    Big Data
    Security
    Technology
    Big Data
    Strategic Review
    Talent Development
  • 続きを読む
  • Research

  • Scientist program, 10+ rolling grants to get high quality data
  • Q3 2018

  • Big Data
    Data 1TB+. Tech upgrade to handle next petabyte
    Security
    Q3: Additional white hat and tiger teams
    Technology
    Shift to fast parallel blockchains for different WHO data sets
  • Pharma

  • Outreach program to determine data needs
  • Q4 2018

  • Big Data
    Data PB+. Tech Upgrade to handle next exabyte
    Strategic Review
    Maximising growth, value and social impact
    Talent Development
    Funnel, bring in and develop top talent
  • Stakeholder

  • Data stakeholder program starts to ensure buy-in
  • Q1 2019

  • Research
    Scientist program, 5-10 grants to get high value data
    API Development
    Develop API for third party integration, promotion and support
    Data Hackathons
    Promote high profile medical hackathons
  • 2019

  • Research
    API Development
    Data Hackathons
    Pharma
    Partner Creation
    Publications
    Standards
    Big Data
    Pharma
    Symposium
    Technology
    EHR/EMR
    Smartcard
    Strategic Review
    Big Data
    Symposium
    Pharma
  • HIPAA & FDA

  • Compliance completed
  • Q2 2019

  • Pharma
    Partnerships closed with 5-10 companies
    Partner Creation
    Research and build high value data partners
    Publications
    Target for first publications with epidemiological trends
  • Research

  • Outreach program 1-3 grants gets best data
  • Q3 2019

  • Standards
    Formation of Medical Blockchain standards group
    Big Data
    Tech EB+ Upgrade to handle next 10EBs
    Pharma
    Partnerships closed with 1-3 companies
  • Team Growth

  • Headhunting world class talent in line with nee
  • Q4 2019

  • Symposium
    Annual Big Data IT & Science symposium for MediChain
    Technology
    Upgrade to version 2.0 for scale and security
    EHR/EMR
    Systems start to acquire patient data to MediChain
  • Talent Search

  • Attracting great talent. Includes hackathons
  • Q1 2020

  • Smartcard
    Initiation of Doctor and Patient Smartcard program
  • Partner Creation

  • Research and build high value data partne
  • Q2 2020

  • Strategic Review
    Maximising growth, value and social impact
  • Pharma

  • Partnerships developing 10-15 companies
  • Q3 2020

  • Big Data
    Data 10EB+. Tech Upgrade to handle next stage
  • Research

  • Scientist Program, 3-5 grants to get high value data
  • Q4 2020

  • Symposium
    Aims to be the leading data provider in the industry
    Pharma
    Partnerships close with 10-20 companies
  • EHR/EMR

  • Integration between EMR and MediChain complet
  • Analysis

  • Ongoing operational needs analysis
  • Big Data

  • Data 1TB+. Tech upgrade to handle next petabyte
  • Security

  • Q3: Additional white hat and tiger teams
  • Technology

  • Shift to fast parallel blockchains for different WHO data sets
  • Big Data

  • Data PB+. Tech Upgrade to handle next exabyte
  • Talent Development

  • Funnel, bring in and develop top talent
  • Research

  • Scientist program, 5-10 grants to get high value data
  • API Development

  • Develop API for third party integration, promotion and support
  • Data Hackathons

  • Promote high profile medical hackathons
  • Pharma

  • Partnerships closed with 5-10 companies
  • Partner Creation

  • Research and build high value data partners
  • Publications

  • Target for first publications with epidemiological
  • Standards

  • Formation of Medical Blockchain standards group
  • Big Data

  • Tech EB+ Upgrade to handle next 10EBs
  • Pharma

  • Partnerships closed with 1-3 companies
  • Symposium

  • Annual Big Data IT & Science symposium for MediChain
  • EHR/EMR

  • Systems start to acquire patient data to MediChain
  • Smartcard

  • Initiation of Doctor and Patient Smartcard program
  • Strategic Review

  • Maximising growth, value and social impact
  • Big Data

  • Data 10EB+. Tech Upgrade to handle next stage
  • Symposium

  • Aims to be the leading data provider in the industry
  • Pharma

  • Partnerships close with 10-20 companies
  • Technology

  • Upgrade to version 2.0 for scale and security

アクティビティ

アクティビティ:
84
LOW
投稿:
412
MEDIUM
ビュー:
3 659
LOW
Activity:
84
LOW
Merit:
0
VERY LOW
Posts:
412
MEDIUM
Views:
3 659
LOW
Users:
224
MEDIUM
投稿:
117
MEDIUM
フォロワー:
14 522
VERY HIGH
好き:
14 283
VERY HIGH
評価:
4.90
VERY HIGH
レビュー:
88
MEDIUM
フォロワー:
3 610
MEDIUM
ツイート:
987
VERY HIGH
30 Days Growth:
-862
メンバー:
6 092
HIGH
30 Days Growth:
-661
アレクサ
ランク:
3 287 017
VERY LOW
デルタ:
2 076 511
Year commits:
23
Watchers:
0
Stars:
0
Forks:
1
Open issues:
0

チーム

検証済み 4%

注意。確認されていないメンバーは実際にチームのメンバーではないというリスクがあります

CEO and Founder
未確認
Medical Doctor, Epidemiologist
未確認
Blockchain Engineer
未確認
Deepak Jha
Business Development and Token Purchaser Relations
未確認
Business Development and Operations
未確認
PR Specialist and Designer
未確認
Creative Director / UX Specialist and Designer
未確認
UX/UI Designer and Developer
検証済み
Software Developer
未確認
Electronic Health Records Specialist
未確認
Business Development & Finance
未確認
Business Development
未確認
Business Development - Japan
未確認
Business Development
未確認
Business Development
未確認
Business Development
未確認
Business Development
未確認
Business Development
未確認
Business Development
未確認
Business Development & Marketing
未確認
Business Development
未確認
Business Development
未確認
Business Development
未確認

MediChain Interviews

Rob Moya
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
My dad has been a role model for me as a Costa Rican Physician who has proven that with a lot of effort you can achieve great things and I wanted to help save lives as he has done many times before, Medichain is trying to do this and more by using blockchain. I'm proud to be part of this project.

Last News

N/A
5.0 11
ICOプロファイル ビジョン アクティビティ 潜在的な 製品 チーム

MediChain Reviews

thetechinsider.org
reviews

Summary

To conclude, MediChain is used to keep your medical records and data stored in one place. With blockchain, it keeps them privatized and secure from third-party hackers. Once this ICO makes their product and have a physical representation it, it could disrupt the medical industry and make it more efficient.

Positives
Decentralized Data Gathering: With MediChain, doctors, nurses, and other registered pharmaceuticals can use your data to help diagnose you and give you treatment based off your health history.
Smart Contracts: When using MediChain, smart contracts are made to give a limited time for medical experts to view the patient’s data.
Benefits all Medic Experts: MediChain provides benefits to doctors, insurers and pharmaceutical companies.

Negatives
Product Needed: We want to see a beta test of a MediChain to see if its product can work in a realistic environment.
Competition: How will MediChain can do well when placed against their competitors? Is their product innovative enough to get them the most market share?
Data Protection: While blockchain can be used to protect medical data, what will MediChain do if hacks occur and their data is compromised?

続きを読む
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
免責事項とリスクに関する警告をお読みください。 免責事項とリスクの警告を表示します。
    

免責事項&リスクの警告     

このオファーは、オファーと他の一般に公開されている情報によってのみ提供される情報に基づいています。トークンの販売または交換のイベントは、ICOholderとは全く無関係であり、ICOholderはそれに関与していません(技術サポートやプロモーションを含む)。 ICOholderとの関係がない人物からのトークンの売り上げは、顧客が全体のトークンセクター内で行われている活動を追跡するのを助けるためにのみ表示されます。この情報は、あなたが頼りにするべきアドバイスにはなりません。弊社サイトのコンテンツに基づいて、行動を取る、または控える前に、プロフェッショナルまたはスペシャリストの助言を得るか、またはお客様のデューデリジェンスを実施する必要があります。トークンの取得に関してコントリビュータによって入力された条件は、トークンの発行者とトークンの発行者であり、ICOholderはそのようなトークンの販売者ではありません。 ICOholderは、トークンの販売に関して第三者が行ったいかなる表明についても法的責任を負いません。また、契約違反の申し立ては、ここに記載されたトークン発行会社に対して直接行われなければなりません。     

このトークン販売の性質、妥当性または合法性について懸念がある場合は、 [email protected] までご連絡ください。あなたの懸念事項に関する詳細情報と一緒に。

Planning an ICO? We can help with a wide range of support for all stages of your ICO